On 4 November 2016
Pfizer will hold a meeting of the Board of Directors of the Company on 4 November 2016 to consider and take on record the unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2016 (Q2).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
